JP2023502940A5 - - Google Patents

Info

Publication number
JP2023502940A5
JP2023502940A5 JP2022528026A JP2022528026A JP2023502940A5 JP 2023502940 A5 JP2023502940 A5 JP 2023502940A5 JP 2022528026 A JP2022528026 A JP 2022528026A JP 2022528026 A JP2022528026 A JP 2022528026A JP 2023502940 A5 JP2023502940 A5 JP 2023502940A5
Authority
JP
Japan
Prior art keywords
seq
lysin
polypeptide
sequence number
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022528026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502940A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/060389 external-priority patent/WO2021097192A1/en
Publication of JP2023502940A publication Critical patent/JP2023502940A/ja
Publication of JP2023502940A5 publication Critical patent/JP2023502940A5/ja
Pending legal-status Critical Current

Links

JP2022528026A 2019-11-14 2020-11-13 溶解素－抗微生物ペプチド（ａｍｐ）ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用 Pending JP2023502940A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962935479P 2019-11-14 2019-11-14
US62/935,479 2019-11-14
PCT/US2020/060389 WO2021097192A1 (en) 2019-11-14 2020-11-13 Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof

Publications (2)

Publication Number Publication Date
JP2023502940A JP2023502940A (ja) 2023-01-26
JP2023502940A5 true JP2023502940A5 (enExample) 2023-11-20

Family

ID=75912341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528026A Pending JP2023502940A (ja) 2019-11-14 2020-11-13 溶解素－抗微生物ペプチド（ａｍｐ）ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用

Country Status (4)

Country Link
US (1) US20220411473A1 (enExample)
EP (1) EP4058468A4 (enExample)
JP (1) JP2023502940A (enExample)
WO (1) WO2021097192A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210330738A1 (en) * 2018-03-29 2021-10-28 Contrafect Corporation Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria
US20250002548A1 (en) * 2021-11-08 2025-01-02 Emory University Wild Boar Cathelicidin Peptide Variants and Vectors Encoding the Same for Uses in Managing Coronavirus Infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2699689A4 (en) * 2011-04-21 2014-12-17 Univ Utrecht Holding Bv STREPTOCOCCUS BACTERIOPHAGEN LYSINE FOR THE TREATMENT OF GRAM-POSITIVE BACTERIA IN PETS AND UTILITIES
WO2012159774A1 (en) * 2011-05-26 2012-11-29 Dsm Ip Assets B.V. Novel listeria bacteriophage p825n and uses thereof
US8790639B2 (en) * 2012-03-28 2014-07-29 The United States Of America, As Represented By The Secretary Of Agriculture Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
BR112020011433A2 (pt) * 2017-12-12 2020-12-01 Contrafect Corporation identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa
CN112368376A (zh) * 2018-03-29 2021-02-12 康特拉费克特公司 溶素-抗微生物肽(amp)多肽构建体、溶素、其分离的编码多核苷酸及其用途
US10988520B2 (en) * 2018-03-29 2021-04-27 Contrafect Corporation Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
US20210330738A1 (en) * 2018-03-29 2021-10-28 Contrafect Corporation Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria

Similar Documents

Publication Publication Date Title
JP2021533728A5 (enExample)
US12144845B2 (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
JP2021519083A5 (enExample)
Łusiak-Szelachowska et al. Bacteriophages and lysins in biofilm control
JP2024010053A5 (enExample)
IL277119B2 (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
JP2021506769A5 (enExample)
JP6483058B2 (ja) 抗菌剤と分散剤または接着阻害剤組成物
IL313959A (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
Gawande et al. Antibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria
JP2024010053A (ja) シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定
Khan et al. Antibiotics application strategies to control biofilm formation in pathogenic bacteria
Dua et al. Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?
JP2023502940A5 (enExample)
JP2021519311A5 (enExample)
Łusiak-Szelachowska et al. Anti-biofilm activity of bacteriophages and lysins in chronic rhinosinusitis.
JP2021508501A (ja) Ｐｓｅｕｄｏｍｏｎａｓ感染症を処置するためのバクテリオファージ組成物
US9078859B2 (en) Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
JP2022526978A5 (enExample)
RU2020129478A (ru) Полипептидные конструкции лизин-противомикробный пептид (amp), лизины, выделенные полинуклеотиды, кодирующие их, а также варианты их применения
HK40086790A (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
RU2020131450A (ru) Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных бактерий
US12606640B2 (en) Recombinant antimicrobial multidomain polypeptide, methods of producing and uses thereof
de Oliveira Costa et al. Therapeutic options for treatment of infections by pathogenic biofilms
RU2021128336A (ru) Лизины и их производные с бактерицидной активностью против pseudomonas aeruginosa в присутствии сыворотки крови человека